New Elsevier Book Examines Complex Mechanisms Relating to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
176
New Elsevier Book Examines Complex Mechanisms Relating to Cardiac Diseases from Pathophysiological and Clinical Viewpoints

CAMBRIDGE, MA --(Marketwired - April 05, 2017) - Elsevier , the information analytics company specializing in science and health, today announced the publication of The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches , edited by Udi Nussinovitch. A state-of-the-art collection of current information regarding medical cardiac complications of prevalent rheumatic, autoimmune and inflammatory diseases, the book resulted from an extended coordinated collaboration of 154 distinguished scientists from 31 countries around the globe. Elsevier also announced the publication of another cardiology book.

The Heart in Rheumatic, Autoimmune and Inflammatory Diseases focuses on aspects of pathophysiological processes, clinical presentations, screening tests, prognostic implications and novel therapeutic approaches. It presents up-to-date 'level of evidence' and 'strengths of recommendations' for suggested therapies, and reviews all randomized clinical trials, meta-analyses and other supporting published clinical findings.

Learn more about the pathophysiology of autoimmunity in this sample chapter.

Dr Nussinovitch carries out his clinical work at the Rambam Healthcare Campus, a tertiary medical facility and leading referral center in northern Israel, academically affiliated to the Technion Institute of Technology, Israel. He has dedicated his research primarily to cardiac autoimmunity and autoinflammation, cardiac manifestations of systemic diseases, cell- and gene-based cardiac therapies, and the modulation of the cardiac electrophysiologic substrate for therapeutic purposes. Dr. Nussinovitch has published articles in leading rheumatologic and cardiovascular journals, as well as several chapters in scientific textbooks, mostly dealing with cardiac autoimmunity. He has received multiple awards and serves as a reviewer for prestigious rheumatologic and cardiac journals.

The two new cardiology titles are:

In order to meet content needs in cardiology, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books, which will educate the next generation of cardiologists, and provide critical foundational content for information professionals, are key examples of how Elsevier is enabling science to drive innovation.

Note for Editors Only credentialed media can request eBook review copies by email, sciencereviewcopies@elsevier.com

About Elsevier Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect , Scopus , ClinicalKey and Sherpath . Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell , more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy . Elsevier is part of RELX Group , a world-leading provider of information and analytics to professionals and business customers, in a wide range of industries. www.elsevier.com

Image Available: http://www.marketwire.com/library/MwGo/2017/4...d5b10f.jpg

Media Contact Pam Foote Publicity Contact, Science & Technology Books, Elsevier footep@reedelsevier.com +1-978-837-8182

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 111

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 78

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 170

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 103

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 55

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 161

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 89

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 61

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 120

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading

Top 5 Most Recently Viewed Articles

Gap Inc. Sees Minor Sales Growth Amid Market Challenges

Updated Category News Views 254

Gap Inc. Experiences Modest Growth Gap Inc. demonstrated resilience in a challenging market, achieving a 1% increase in net sales compared to the previous year. The comparable sales rose by 3%, reflecting the brand's enhancement strategies. Brand Performance Highlight Each of Gap Inc.'s four major brands—Old Navy, Gap, Banana Republic, and Athleta—gained market share,...

Continue Reading
Innovative Lock Design Enhances Security for Commercial Trailers

Updated Category News Views 761

The SMART LOC: A Game-Changer for Trucking Security In a world where cargo theft is a persistent challenge, the development of an innovative solution is essential. Enter the SMART LOC, a new locking mechanism designed specifically for commercial trailers. This invention aims to significantly enhance security for trucking professionals, ultimately providing much-needed...

Continue Reading
GXO Logistics Prepares for First Quarter Earnings Call Soon

Updated Category News Views 198

GXO Logistics Set for First Quarter Earnings Presentation GXO Logistics, Inc. (NYSE: GXO) is preparing for its first quarter earnings conference call, which is scheduled for May 8, 2025, at 8:30 a.m. Eastern Time. During this call, the company will share its financial results and key insights into its business performance. Interested participants are encouraged to join in...

Continue Reading
Legal Action Against Everus Construction Group for Investors

Updated Category News Views 132

Overview of Legal Proceedings Against Everus Construction Group Everus Construction Group, Inc. (NYSE: ECG) is currently facing significant legal challenges as a result of alleged securities law violations. The situation has prompted attention from shareholders and investors alike. The Gross Law Firm has taken the initiative to notify shareholders regarding this serious...

Continue Reading
Nxera Pharma and Cancer Research UK Collaborate to Combat Cancer

Updated Category News Views 121

Nxera Pharma Joins Forces with Cancer Research UK for Innovative Trials HTL0039732, a promising oral EP4 antagonist developed by Nxera, shows potential in tackling various types of cancer, especially when paired with leading immunotherapies. Currently, this drug is making progress through its Phase 1/2a clinical trials, highlighting its potential effectiveness across a...

Continue Reading